Newsroom
March 30, 2021
Bioventus Acquires Bioness, Inc.
DURHAM, NC – March 30, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
March 25, 2021
Bioventus Inc. Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Guidance
DURHAM, NC – March 25, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
March 11, 2021
Bioventus Reports First Patients Enrolled in Phase 1 Clinical Trial of MOTYS(TM) (PTP-001) for the Treatment of Knee OA
DURHAM, NC – March 11, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in solutions for innovative healing, reported…
March 4, 2021
Larry Chen Joins Bioventus as Managing Director, China and Asia Pacific
DURHAM, NC – March 4, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…
March 1, 2021
Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021
DURHAM, NC – March 1, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…
February 10, 2021
Bioventus Announces Pricing of Initial Public Offering
DURHAM, NC – February 10, 2021 – Bioventus Inc. ("Bioventus" or the “Company”) today announced the pricing of its initial public offering of…
February 4, 2021
Bioventus Announces Launch of Initial Public Offering
DURHAM, NC – February 4, 2021 – Bioventus Inc. ("Bioventus" or the “Company”), today announced that it has commenced the initial public offering of…
January 19, 2021
Miguel O. Beltrán-Delgado Joins Bioventus as Senior Vice President of Operations
DURHAM, NC – January 19, 2021 – Bioventus, a global leader in Innovations For Active Healing, has appointed Miguel O. Beltrán-Delgado as Senior Vice…
November 18, 2020
Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA
DURHAM, NC – November 18, 2020 – Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…
November 16, 2020
Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy
DURHAM, NC – November 16, 2020 – Bioventus, a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior Vice President…
Search News
Media Inquiries
Thomas Hill
Director of Corporate Communications
919.474.6715
[email protected]
Download Library
Corporate and Brand Logos
Download Now
Product Images
Download Now
